These data demonstrate that hepatocyte HMGB1 regulates lipid accumulation via β-oxidation-related gene expression, suggesting β-oxidation as a downstream target of intracellular HC-HMGB1 during NAFLD. Here, HMGB1 is linked to metabolic dysfunction-associated steatotic liver disease.